A Respiratory Health Study
Currently Recruiting
30 Nov 2026
Up to $8,290
Melbourne, Australia
This clinical study is investigating an investigational vaccine targeting respiratory viruses such as RSV, HMPV and PIV. This investigational vaccine is being developed to address the lack of currently licensed vaccines for prevention of HPMV and PIV. Researchers are evaluating this investigational vaccine to better understand its safety, tolerability and how the body responds to it.Â
By conducting this study, researchers hope to gain a better understanding of the medication and how it behaves in different populations, which may help support future clinical development and the design of subsequent research studies to help with protection from respiratory viruses.Â
This study is sponsored by a pharmaceutical company.
Join our clinical trial
This is a first-in-human (FIH) study, meaning it is the first time the investigational vaccine is being tested in people. The study has been carefully designed with strict safety protocols and has been approved by an independent ethics committee. It is not known whether the study drug may cause unexpected, serious, or life-threatening side effects. While these are considered unlikely, you will be carefully monitored throughout the study and provided with prompt treatment if any such effects occur.Â
Before joining, you’ll receive detailed information about the study, meet with a doctor, and have the chance to ask any questions.
What to expect
- Participation in a monitored clinical environmentÂ
- Study visits scheduled Â
- Support from a professional medical teamÂ
- Reimbursement for your time and commitmentÂ
Study schedule
| Intake 1 | Vaccine visit:
30 November 2026 |
Follow-up visits:
1 December 2026 – 29 November 2027 |
Study dates are subject to change. Our team will confirm details with you during the screening process.
Trial details
Study medication
The study drug or placebo will be administered as an intramuscular injection in the upper arm.
Study duration
- 1 dosing visit
- 8 follow-up visits
- 1 phone call
Additional eligibility
- Weigh above 50kgÂ
- Non-smokers, or smoking no more than 10 cigarettes (or equivalent) per dayÂ
- Not pregnant or breastfeeding  Â
- Willing to follow contraception guidelines (If applicable)Â Â
- Willing and able to attend all study visits and follow instructions  Â
Ethics
An independent ethics committee has approved this clinical trial.
Are you a match?
Age
60 - 84 years old
Remuneration
Up to $8,290 *with screening reimbursement.
Full details outlined in consent form.
Gender
Male, Female (Post-menopausal) or Female of non-childbearing potential
BMI
BMI 18 - 35 kg/m2
Commitment
Appointment only, 8 clinic visits